Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2024

Open Access 01-12-2024 | Hemoptysis | Case Report

A pulmonary artery was embolized in a patient with an occluded pulmonary vein to manage massive hemoptysis

Authors: Dongping Xia, Wenhao Cao, Yi Hu

Published in: BMC Pulmonary Medicine | Issue 1/2024

Login to get access

Abstract

Background

Stenosis and obliteration of the pulmonary vein can be developed by multiple diseases and might cause hemoptysis. Traditional therapy including surgical procedure and conservative treatments might be inappropriate choices to manage massive hemoptysis.

Case presentation

A 64-year-old man, diagnosed with advanced stage IVA lung squamous cell carcinoma, presented with dyspnea and recurrent, massive hemoptysis. An initial contrast-enhanced computed tomography revealed a giant tumor in the left lung hilus and occlusion of the left superior pulmonary vein. Despite immediate selective bronchial artery embolization and simultaneous embolization of an anomalous branch of the internal thoracic artery, the massive hemoptysis continued. Subsequently, embolization of the left superior pulmonary artery was performed, achieving functional pulmonary lobectomy, which successfully treated the hemoptysis without relapse during a six-month follow-up. The patient continues to undergo cancer therapy and remains stable.

Conclusions

This case successfully managed massive hemoptysis associated with lung cancer invasion into the pulmonary vein through functional pulmonary lobectomy via embolization of the corresponding pulmonary artery.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fender EA, Widmer RJ, Hodge DO, et al. Assessment and Management of Pulmonary vein occlusion after atrial fibrillation ablation. JACC Cardiovasc Interv. 2018;11:1633–39.CrossRefPubMed Fender EA, Widmer RJ, Hodge DO, et al. Assessment and Management of Pulmonary vein occlusion after atrial fibrillation ablation. JACC Cardiovasc Interv. 2018;11:1633–39.CrossRefPubMed
3.
4.
go back to reference Fender EA, Widmer RJ, Hodge DO, et al. Severe pulmonary vein stenosis resulting from ablation for Atrial Fibrillation: Presentation, Management, and clinical outcomes. Circulation. 2016;134:1812–21.CrossRefPubMed Fender EA, Widmer RJ, Hodge DO, et al. Severe pulmonary vein stenosis resulting from ablation for Atrial Fibrillation: Presentation, Management, and clinical outcomes. Circulation. 2016;134:1812–21.CrossRefPubMed
5.
go back to reference Choe DH, Lee JH, Lee BH, et al. Obliteration of the pulmonary vein in lung cancer: significance in assessing local extent with CT. J Comput Assist Tomogr. 1998;22:587–91.CrossRefPubMed Choe DH, Lee JH, Lee BH, et al. Obliteration of the pulmonary vein in lung cancer: significance in assessing local extent with CT. J Comput Assist Tomogr. 1998;22:587–91.CrossRefPubMed
6.
go back to reference Marcelin C, Soussan J, Desmots F, et al. Outcomes of Pulmonary Artery Embolization and Stent Graft Placement for the treatment of Hemoptysis caused by lung tumors. J Vasc Interv Radiol. 2018;29:975–80.CrossRefPubMed Marcelin C, Soussan J, Desmots F, et al. Outcomes of Pulmonary Artery Embolization and Stent Graft Placement for the treatment of Hemoptysis caused by lung tumors. J Vasc Interv Radiol. 2018;29:975–80.CrossRefPubMed
Metadata
Title
A pulmonary artery was embolized in a patient with an occluded pulmonary vein to manage massive hemoptysis
Authors
Dongping Xia
Wenhao Cao
Yi Hu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2024
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-024-02968-0

Other articles of this Issue 1/2024

BMC Pulmonary Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine